March 29 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS GRANTED PRIORITY REVIEW STATUS FROM HEALTH CANADA FOR VASCEPA®
* HLS THERAPEUTICS INC - HLS NDS FILING TO OCCUR IN APRIL 2019
March 29 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS GRANTED PRIORITY REVIEW STATUS FROM HEALTH CANADA FOR VASCEPA®
* HLS THERAPEUTICS INC - HLS NDS FILING TO OCCUR IN APRIL 2019